Greater Glasgow and Clyde Medicines

Restrictions:

The oro-dispersible tablets are restricted to second line treatment for patients for whom standard tablets are not appropriate.

Prescribing Notes:

• National guidance on the pharmacological management of migraine can be found in SIGN 155 (Sept 2022).
• Local guidance and referral pathway for migraine is also available here (2021 booklet)

BNF Link

Restrictions:

Sumatriptan nasal spray is restricted to use in patients for whom other formulations are not suitable or effective.

Prescribing Notes:

• National guidance on the pharmacological management of migraine can be found in SIGN 155 (Sept 2022).
• Local guidance and referral pathway for migraine is also available here (2021 booklet)

BNF Link

Restrictions:

Sumatriptan injection is restricted to use in patients for whom other formulations are not suitable or effective.

Prescribing Notes:

• National guidance on the pharmacological management of migraine can be found in SIGN 155 (Sept 2022).
• Local guidance and referral pathway for migraine is also available here (2021 booklet)

BNF Link

Prescribing Notes:

• National guidance on the pharmacological management of migraine can be found in SIGN 155 (Sept 2022).
• Local guidance and referral pathway for migraine is also available here (2021 booklet)

BNF Link